Yu Li

Yu Li has over 16 years of experience in statistical programming and biostatistics. Currently, Yu Li holds the position of Sr. Director of Statistical Programming at Kura Oncology, Inc. Prior to this, Yu Li served as the Director of Statistical Programming at Principia Biopharma and CymaBay Therapeutics. Previous roles include Senior Manager of Statistical Programming at Pharmacyclics, an AbbVie Company, Principal 2 of Statistical Programming at BioMarin Pharmaceutical Inc., and Biostatistical Programming Manager at Amgen. Yu Li started their career as a Statistical Analyst Consultant at MedFocus, working onsite at Eli Lilly and Company.

Yu Li has a Bachelor's degree in Biological Science and Technology from Tsinghua University. They also have a Master of Science degree in Applied Statistics from Indiana University–Purdue University Indianapolis. In addition, Yu Li holds a Doctor of Philosophy degree in Biochemistry and Molecular Biology from the Indiana University School of Medicine.